Shuttle Pharmaceuticals Files 8-K on Officer/Director Changes
Ticker: SHPH · Form: 8-K · Filed: Sep 8, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Sep 8, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, corporate-governance
TL;DR
Shuttle Pharma's board and exec team saw changes on Sept 8, 2025.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on September 8, 2025, reporting on the departure of directors or certain officers, the election of directors, and the appointment of certain officers. The filing also covers compensatory arrangements for certain officers. The company is incorporated in Delaware and its principal executive offices are located in Gaithersburg, MD.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational execution.
Risk Assessment
Risk Level: medium — Changes in key personnel and executive compensation can signal internal shifts that may affect future performance or strategy.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Principal executive offices
- September 8, 2025 (date) — Date of earliest event reported
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers, as well as details on compensatory arrangements for certain officers.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on September 8, 2025.
What is the principal executive office address for Shuttle Pharmaceuticals Holdings, Inc.?
The principal executive offices are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is the SIC code for Shuttle Pharmaceuticals Holdings, Inc.?
The Standard Industrial Classification (SIC) code is 2834 for Pharmaceutical Preparations.
Filing Stats: 498 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-09-08 17:00:47
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 34KB
- 0001641172-25-026867.txt ( ) — 197KB
- shph-20250908.xsd (EX-101.SCH) — 3KB
- shph-20250908_lab.xml (EX-101.LAB) — 33KB
- shph-20250908_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Dated: September 8, 2025 By: /s/ Christopher Cooper Name: Christopher Cooper Title: Interim Chief Executive Officer 3